MABVAX THERAPEUTICS HOLDINGS, INC. 4
4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Jan 3, 2017
Insider Transaction Report
Form 4
EISENBERG JEFFREY F
Director
Transactions
- Award
Option to Purchase Common Stock
2017-01-01$3.38/sh+2,300$7,774→ 2,300 totalExercise: $3.38Exp: 2027-01-01→ Common Stock (2,300 underlying)
Footnotes (1)
- [F1]Such Options shall vest in equal annual installments over a three year period.